Quartz Mountain Resources Closes $1.7 Million Financing
Quartz Mountain Resources Ltd. has closed a $1.7 million financing to enhance its exploration efforts in British Columbia's mining sector.
QTREX Quantum Regains Compliance with Nasdaq Bid Price Rule
QTREX Quantum Ltd. regains compliance with Nasdaq's minimum bid price requirement, ensuring continued trading under the symbol QTEX.
Freight Technologies announces share exchange agreements
Freight Technologies, Inc. restructures its capital by exchanging preferred shares for ordinary shares, impacting its financial flexibility.
POMDOCTOR Ltd to Terminate ADR Program, List Shares Directly
POMDOCTOR Ltd announces termination of its ADR program and plans to list Class A shares directly on Nasdaq, reflecting strategic operational changes.
Coca-Cola Europacific Partners confirms share buyback program
Coca-Cola Europacific Partners plc confirms share buyback, purchasing 138,046 shares in the U.S. and 49,900 in London as part of its strategy.
Ericsson Announces Share Buybacks from October 12-16, 2026
Ericsson repurchased over 4 million shares in a recent buyback program, reinforcing its commitment to shareholder value in the communications equipment sector.
GoPro files amended quarterly report for Q1 2026
GoPro, Inc. files an amended quarterly report, revealing updates to its financials for Q1 2026, impacting the photographic equipment industry.
Canaan Inc. Appoints KPMG in Singapore as Auditor
Canaan Inc. has appointed KPMG in Singapore as its new independent auditor, enhancing its governance and global operations.
Inter & Co Discontinues Level II Sponsored BDR Program
Inter & Co, Inc. discontinues its Level II Sponsored BDR Program, transitioning to Unsponsored Level I BDRs, impacting the commercial banking sector.
GSK's Jemperli Approved for Advanced Rectal Cancer Treatment
GSK plc's Jemperli receives FDA approval as the first immunotherapy for advanced rectal cancer, offering new hope for patients.
argenx SE reveals Phase 3 results for autoimmune myositis drug
argenx SE announces Phase 3 results for efgartigimod in autoimmune myositis, showcasing significant patient improvements. Presentation at ACR Convergence 2026 set.
GoPro amends Q2 2026 report, highlights financial updates
GoPro, Inc. has filed an amended quarterly report for Q2 2026, revealing important financial updates that may impact the company and its industry.
RedHill Biopharma Secures $2.9 Million NCI Grant for Trials
RedHill Biopharma receives $2.9 million grant from NCI to study Opaganib in combination with CAR T-cell therapy for multiple myeloma.
Novo Nordisk launches DKK 15 billion share repurchase program
Novo Nordisk A/S announces a share repurchase program worth DKK 15 billion, reflecting confidence in financial strength and enhancing shareholder value.
HDFC Bank reports strong financial results for Q2 2026
HDFC Bank announces its unaudited financial results for Q2 2026, showcasing robust performance and implications for the banking sector.
Brainsway Ltd. Partners with Inland Psychiatry Medical Group
Brainsway Ltd. announces a strategic collaboration with Inland Psychiatry Medical Group to enhance interventional psychiatry treatments.
Enlivex Announces Cost Reduction Plan Amid Clinical Focus
Enlivex Ltd. reveals a cost reduction plan to focus on its Phase 2b trial of Allocetra™ for knee osteoarthritis, including workforce cuts and salary reductions.
STMicroelectronics announces share buyback results for October
STMicroelectronics N.V. reports on its recent share buyback program, acquiring 492,285 shares to enhance shareholder value.
LG Display Faces Potential Unfaithful Disclosure Designation
LG Display Co., Ltd. may be designated as an 'Unfaithful Disclosure Corporation' due to delayed disclosures, raising governance concerns in the industry.
HDFC Bank re-appoints Lily Vadera as Independent Director
HDFC Bank announces the re-appointment of Lily Vadera as Independent Director, effective November 26, 2026, amid leadership changes.